 |
 |
 |
 |
 |
|
|
| Article 1 to 10 out of 257
|
|
-
BioFocus DPI and ZoBio announce marketing agreement
(17 Nov 2008)
BioFocus DPI and ZoBio announced that they have signed a worldwide marketing and sales agreement for ZoBio’s fragment-based NMR technologies. Under the terms of the agreement BioFocus DPI will sell ZoBio’s services either as a stand-alone ......
-
Applied Biosystems and Asuragen collaborate with the Critical Path Institute to improve drug toxicity screening
(10 Nov 2008)
Drug toxicity is a leading cause of pre-clinical drug failures. The US Food and Drug Administration (FDA) and other regulatory organisations have called upon the pharmaceutical industry to develop more effective tools to help avoid these costly ......
-
InteRNA Technologies and VU University Medical Center to Develop microRNA-based Diagnostics and Therapeutics for Cancer
(03 Nov 2008)
InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announced the signing of a framework research agreement to develop microRNA (miRNA)-based diagnostics and therapeutics for cancer using InteRNA’s proprietary library ......
-
Enigma Diagnostics Announces Patent Licence With Applied Biosystems
(27 Oct 2008)
Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems. The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid ......
-
Malvern joins industry group in developing common model for analyzer integration
(24 Oct 2008)
Malvern Instruments announced its participation in the newly-formed OPC Analyzer Device Integration Working Group. The group has been constituted to develop a common method for data exchange and an analyzer data model for process and laboratory ......
-
NorDiag enters distribution and collaboration agreement with Molzym
(22 Oct 2008)
NorDiag has entered into two distribution agreements with German based Molzym GmbH & Co KG covering Molzym’s molecular diagnostic products. The first agreement is geographically restrained to USA and Canada, while the second agreement covers ......
-
EMSA, Cefic and Cedre sign agreement for co-operation in the field of marine pollution involving chemicals
(21 Oct 2008)
In the EMSA premises in Lisbon, Mr Willem de Ruiter, Executive Director of the European Maritime Safety Agency (EMSA), Mr Joachim Krueger, Executive Director of the Energy, HSE and Logistics Programme of the European Chemical Industry Council ......
-
Cell Projects licenses Electroporation Technologies from Queen’s University, Canada
(16 Oct 2008)
Cell Projects (UK) has entered into a wide ranging commercial license and joint development agreement with Queen’s University, Kingston, Ontario, Canada, covering several new Electroporation platform technologies for Adherent and InSitu Cell ......
-
Kinaxo Enters into an Agreement with Boehringer Ingelheim
(15 Oct 2008)
Kinaxo Biotechnologies GmbH announced that it has entered into a two-year collaboration with Boehringer Ingelheim. Under the agreement Kinaxo will apply its new platform technologies to studies on drug mode of action and target identification. ......
-
Cooperation Makes Microreactor Technology Accessible to Fine-Chemistry and Pharmacy
(13 Oct 2008)
The Dutch companies Micronit Microfluidics, FutureChemistry and Flowid announced the start of a cooperation named Access2Flow. Together, the three companies will offer a new generation of microreactor systems that enable chemists to quickly and ......
|
|
|
|
|